CD44 and hepatocellular carcinoma: CD13 is a myeloid bone marrow-derived marker and CD44 antigen is a cell surface glycoprotein involved in cell–cell interactions, cell adhesion and migration, both of which are overexpressed in metastasis and have poor prognosis in HCC.